» Authors » Cheng Zhan

Cheng Zhan

Explore the profile of Cheng Zhan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 245
Citations 3250
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng D, Chen Z, Li M, Yi Y, Hu Z, Valeria B, et al.
Eur J Med Res . 2025 Mar; 30(1):173. PMID: 40089771
Objectives: We compared the overall survival (OS) and cancer-specific survival (CSS) of patients who received radiotherapy and surgery, respectively, in a large population. Methods: In this study, we counted the...
2.
Zhang W, Shan G, Bi G, Hu Z, Yi Y, Zeng D, et al.
Biochim Biophys Acta Mol Cell Res . 2025 Mar; 1872(4):119927. PMID: 40023198
Lactylation, a newly identified post-translational modification, entails the attachment of lactate to lysine residues within proteins, profoundly modulating diverse cellular mechanisms underlying regulated cell death (RCD). This modification encompasses two...
3.
Huang Y, Wu G, Bi G, Cheng L, Liang J, Li M, et al.
Elife . 2024 Dec; 13. PMID: 39729352
Chemotherapy is widely used to treat lung adenocarcinoma (LUAD) patients comprehensively. Considering the limitations of chemotherapy due to drug resistance and other issues, it is crucial to explore the impact...
4.
Chen J, Cai M, Zhan C
Neurosci Bull . 2024 Dec; PMID: 39704987
In the face of constantly changing environments, the central nervous system (CNS) rapidly and accurately calculates the body's needs, regulates feeding behavior, and maintains energy homeostasis. The arcuate nucleus of...
5.
Tong Z, Xu X, Shen C, Yang D, Li Y, Li Q, et al.
Biosens Bioelectron . 2024 Nov; 270:116976. PMID: 39591923
Extracellular vesicles (EVs) and EV-derived microRNAs (EV-miRNAs) are emerging as promising circulating biomarkers for early detection of malignant tumors such as non-small cell lung cancer (NSCLC). However, utilization of the...
6.
Zhu J, Wu Z, Shan G, Huang Y, Liang J, Zhan C
Heliyon . 2024 Nov; 10(21):e40150. PMID: 39568844
The epidermal growth factor receptor (EGFR) is a recognized target in tumor treatment. While there is significant focus on inhibiting membrane EGFR and its downstream signaling activation, the ectopic accumulation...
7.
Wu J, Kan E, Zhan C
Phys Chem Chem Phys . 2024 Nov; 26(45):28449-28458. PMID: 39508484
Single-atom catalysts (SACs) have shown promising activity in electrocatalysis, such as CO reduction (CORR), the oxygen evolution reaction (OER) and the oxygen reduction reaction (ORR). Transition-metal-embedded N-doped graphene (M-N-C) with...
8.
Liu L, Huang Z, Zhang J, Wang M, Yue T, Wang W, et al.
Nat Commun . 2024 Oct; 15(1):8632. PMID: 39366937
Rapid glucose supply is crucial for animal survival during stress response. How the timescale of stress-induced glucose release precisely controlled by hypothalamic corticotropin-releasing hormone (CRH) neurons remains unclear. Here, we...
9.
Yang H, Cai J, Huang X, Zhan C, Lu C, Gu J, et al.
Mol Cancer Res . 2024 Oct; 23(1):71-85. PMID: 39352512
Gram-negative (G-) microflora dysbiosis occurs in multiple digestive tumors and is found to be the dominant microflora in the esophageal squamous cell carcinoma (ESCC) microenvironment. The continuous stimulation of G-...
10.
Bian Y, Shan G, Bi G, Liang J, Hu Z, Sui Q, et al.
Redox Biol . 2024 Sep; 77:103361. PMID: 39317105
KRAS is among the most commonly mutated oncogenes in human malignancies. Although the advent of sotorasib and adagrasib, has lifted the "undruggable" stigma of KRAS, the resistance to KRAS inhibitors...